Inventor · disambiguated record
Xuelei Yan
Also filed as: YAN XUELEI
31 granted patents·13 pending applications·67 citations·filing 2004–2024
95Inventor score
Top patents by PatentIndex Score
44 records- 0194US11787762B2Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alphaARCUS BIOSCIENCES INC·Filed 2022·Granted Oct 17, 2023·2 cites·26 claims
- 0293US11407712B2Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2αARCUS BIOSCIENCES INC·Filed 2021·Granted Aug 9, 2022·3 cites·15 claims
- 0392US7524848B2Diaza heterocyclic amide compounds and their usesAMGEN INC·Filed 2007·Granted Apr 28, 2009·24 cites·7 claims
- 0490US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 0588US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0688US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 0787US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 0886US12103907B2Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alphaARCUS BIOSCIENCES INC·Filed 2023·Granted Oct 1, 2024·0 cites·1 claims
- 0986US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1082US2025214930A1Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alphaARCUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1181US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1280US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 1379US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 1479US7605289B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2006·Granted Oct 20, 2009·4 cites·42 claims
- 1578US7402704B2Arylsulfones and uses related theretoAMGEN INC·Filed 2005·Granted Jul 22, 2008·3 cites·18 claims
- 1676US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 1776US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1874US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1972US12384773B2Thiazole compounds and methods of use thereofARCUS BIOSCIENCES INC·Filed 2024·Granted Aug 12, 2025·0 cites·14 claims
- 2071US7659287B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2007·Granted Feb 9, 2010·1 cites·8 claims
- 2170US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 2269US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2367US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2465US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 2564US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2664US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2761US7365075B2Aryl sulfonamide compounds and uses related theretoAMGEN INC·Filed 2004·Granted Apr 29, 2008·1 cites·46 claims
- 2861US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2960US7834047B2Arylsulfonamides and uses related theretoAMGEN INC·Filed 2008·Granted Nov 16, 2010·0 cites·11 claims
- 3059US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 3159US8637576B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2009·Granted Jan 28, 2014·0 cites·4 claims
- 3259US8138190B2Diaza heterocyclic amide compounds and their usesPOWERS JAY P·Filed 2009·Granted Mar 20, 2012·0 cites·5 claims
- 3358US7754890B2Arylsulfones and uses related theretoAMGEN INC·Filed 2008·Granted Jul 13, 2010·0 cites·11 claims
- 3456US8765788B2Tricyclic inhibitors of hydroxysteroid dehydrogenasesPOWERS JAY P·Filed 2008·Granted Jul 1, 2014·0 cites·4 claims
- 3552US11931343B2CD73 inhibitorsARCUS BIOSCIENCES INC·Filed 2019·Granted Mar 19, 2024·0 cites·11 claims
- 3651US7495012B2Arylsulfonamides and uses related theretoAMGEN INC·Filed 2005·Granted Feb 24, 2009·0 cites·21 claims
- 3751US2023024438A1Inhibitors of hif-2alphaARCUS BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3846US2016002185A1Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Application pending·0 cites
- 3945US12410170B22,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compoundsARCUS BIOSCIENCES INC·Filed 2020·Granted Sep 9, 2025·0 cites·13 claims
- 4045US7825122B2Diaza heterocyclic sulfonamide derivatives and their usesAMGEN INC·Filed 2006·Granted Nov 2, 2010·0 cites·25 claims
- 4144US11274105B2Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonistsAMGEN INC·Filed 2019·Granted Mar 15, 2022·0 cites·15 claims
- 4244US8772296B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2007·Granted Jul 8, 2014·0 cites·23 claims
- 4343US11407721B2CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2018·Granted Aug 9, 2022·0 cites·46 claims
- 4442US11208432B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Dec 28, 2021·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Xuelei Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →